536 related articles for article (PubMed ID: 34685596)
1. Exosomes in the Tumor Microenvironment: From Biology to Clinical Applications.
da Costa VR; Araldi RP; Vigerelli H; D'Ámelio F; Mendes TB; Gonzaga V; Policíquio B; Colozza-Gama GA; Valverde CW; Kerkis I
Cells; 2021 Oct; 10(10):. PubMed ID: 34685596
[TBL] [Abstract][Full Text] [Related]
2. Emerging role of tumor microenvironment derived exosomes in therapeutic resistance and metastasis through epithelial-to-mesenchymal transition.
Balaji S; Kim U; Muthukkaruppan V; Vanniarajan A
Life Sci; 2021 Sep; 280():119750. PubMed ID: 34171378
[TBL] [Abstract][Full Text] [Related]
3. The Emerging Roles of Exosomes in the Chemoresistance of Hepatocellular Carcinoma.
Zhang J; Song Q; Wu M; Zheng W
Curr Med Chem; 2021; 28(1):93-109. PubMed ID: 32000636
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal stem cell-derived exosomes in cancer therapy resistance: recent advances and therapeutic potential.
Lin Z; Wu Y; Xu Y; Li G; Li Z; Liu T
Mol Cancer; 2022 Sep; 21(1):179. PubMed ID: 36100944
[TBL] [Abstract][Full Text] [Related]
5. Targeting Epithelial-Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer.
Du B; Shim JS
Molecules; 2016 Jul; 21(7):. PubMed ID: 27455225
[TBL] [Abstract][Full Text] [Related]
6. Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance.
Erin N; Grahovac J; Brozovic A; Efferth T
Drug Resist Updat; 2020 Dec; 53():100715. PubMed ID: 32679188
[TBL] [Abstract][Full Text] [Related]
7. The multifaceted role of exosomes in cancer progression: diagnostic and therapeutic implications [corrected].
Sundararajan V; Sarkar FH; Ramasamy TS
Cell Oncol (Dordr); 2018 Jun; 41(3):223-252. PubMed ID: 29667069
[TBL] [Abstract][Full Text] [Related]
8. Exosomes: composition, biogenesis, and mechanisms in cancer metastasis and drug resistance.
Mashouri L; Yousefi H; Aref AR; Ahadi AM; Molaei F; Alahari SK
Mol Cancer; 2019 Apr; 18(1):75. PubMed ID: 30940145
[TBL] [Abstract][Full Text] [Related]
9. Cancer Stem Cells and Circulatory Tumor Cells Promote Breast Cancer Metastasis.
Malla R; Puvalachetty K; Vempati RK; Marni R; Merchant N; Nagaraju GP
Clin Breast Cancer; 2022 Aug; 22(6):507-514. PubMed ID: 35688785
[TBL] [Abstract][Full Text] [Related]
10. Advances in Therapeutic Targeting of Cancer Stem Cells within the Tumor Microenvironment: An Updated Review.
Dzobo K; Senthebane DA; Ganz C; Thomford NE; Wonkam A; Dandara C
Cells; 2020 Aug; 9(8):. PubMed ID: 32823711
[TBL] [Abstract][Full Text] [Related]
11. The emerging roles of exosomes in anti-cancer drug resistance and tumor progression: An insight towards tumor-microenvironment interaction.
Jena BC; Mandal M
Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188488. PubMed ID: 33271308
[TBL] [Abstract][Full Text] [Related]
12. Cancer stem cell (CSC) resistance drivers.
Najafi M; Mortezaee K; Majidpoor J
Life Sci; 2019 Oct; 234():116781. PubMed ID: 31430455
[TBL] [Abstract][Full Text] [Related]
13. Cancer stem cells (CSCs): key player of radiotherapy resistance and its clinical significance.
Hoque S; Dhar R; Kar R; Mukherjee S; Mukherjee D; Mukerjee N; Nag S; Tomar N; Mallik S
Biomarkers; 2023 Mar; 28(2):139-151. PubMed ID: 36503350
[TBL] [Abstract][Full Text] [Related]
14. The biological functions and clinical applications of exosomes in lung cancer.
Chen R; Xu X; Qian Z; Zhang C; Niu Y; Wang Z; Sun J; Zhang X; Yu Y
Cell Mol Life Sci; 2019 Dec; 76(23):4613-4633. PubMed ID: 31352532
[TBL] [Abstract][Full Text] [Related]
15. Chemoresistance in cancer cells: exosomes as potential regulators of therapeutic tumor heterogeneity.
Sharma A
Nanomedicine (Lond); 2017 Sep; 12(17):2137-2148. PubMed ID: 28805111
[TBL] [Abstract][Full Text] [Related]
16. The cancer stem cell niche: cross talk between cancer stem cells and their microenvironment.
Ye J; Wu D; Wu P; Chen Z; Huang J
Tumour Biol; 2014 May; 35(5):3945-51. PubMed ID: 24420150
[TBL] [Abstract][Full Text] [Related]
17. The Microenvironment of Lung Cancer and Therapeutic Implications.
Mittal V; El Rayes T; Narula N; McGraw TE; Altorki NK; Barcellos-Hoff MH
Adv Exp Med Biol; 2016; 890():75-110. PubMed ID: 26703800
[TBL] [Abstract][Full Text] [Related]
18. Tumour microenvironment: a non-negligible driver for epithelial-mesenchymal transition in colorectal cancer.
Han L; Wang S; Wei C; Fang Y; Huang S; Yin T; Xiong B; Yang C
Expert Rev Mol Med; 2021 Nov; 23():e16. PubMed ID: 34758892
[TBL] [Abstract][Full Text] [Related]
19. Regulation and signaling pathways in cancer stem cells: implications for targeted therapy for cancer.
Zeng Z; Fu M; Hu Y; Wei Y; Wei X; Luo M
Mol Cancer; 2023 Oct; 22(1):172. PubMed ID: 37853437
[TBL] [Abstract][Full Text] [Related]
20. Cancer stem cell-derived exosome-induced metastatic cancer: An orchestra within the tumor microenvironment.
Rashid K; Ahmad A; Meerasa SS; Khan AQ; Wu X; Liang L; Cui Y; Liu T
Biochimie; 2023 Sep; 212():1-11. PubMed ID: 37011805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
